193 related articles for article (PubMed ID: 15304981)
41. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor.
Tavornvipas S; Hirayama F; Takeda S; Arima H; Uekama K
J Pharm Sci; 2006 Dec; 95(12):2722-9. PubMed ID: 16917853
[TBL] [Abstract][Full Text] [Related]
42. Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol.
Jug M; Bećirević-Laćan M; Bengez S
Drug Dev Ind Pharm; 2009 Jul; 35(7):796-807. PubMed ID: 19259876
[TBL] [Abstract][Full Text] [Related]
43. Amphiphilic Cyclodextrin Derivatives for Targeted Drug Delivery to Tumors.
Erdogar N; Varan G; Bilensoy E
Curr Top Med Chem; 2017; 17(13):1521-1528. PubMed ID: 28017158
[TBL] [Abstract][Full Text] [Related]
44. Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology.
Lachowicz M; Stańczak A; Kołodziejczyk M
Curr Drug Targets; 2020; 21(14):1495-1510. PubMed ID: 32538725
[TBL] [Abstract][Full Text] [Related]
45. Cyclodextrin-Based Formulations: A Non-Invasive Platform for Targeted Drug Delivery.
Muankaew C; Loftsson T
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):46-55. PubMed ID: 29024354
[TBL] [Abstract][Full Text] [Related]
46. Metallocyclodextrins in medicinal chemistry.
Oliveri V; Vecchio G
Future Med Chem; 2018 Mar; 10(6):663-677. PubMed ID: 29417824
[TBL] [Abstract][Full Text] [Related]
47. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
[TBL] [Abstract][Full Text] [Related]
48. Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates.
Zou MJ; Cheng G; Okamoto H; Hao XH; An F; Cui FD; Danjo K
World J Gastroenterol; 2005 Dec; 11(47):7457-60. PubMed ID: 16437716
[TBL] [Abstract][Full Text] [Related]
49. Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery.
Yokoyama R; Taharabaru T; Nishida T; Ohno Y; Maeda Y; Sato M; Ishikura K; Yanagihara K; Takagi H; Nakamura T; Ito S; Ohtsuki S; Arima H; Onodera R; Higashi T; Motoyama K
J Control Release; 2020 Dec; 328():722-735. PubMed ID: 33002523
[TBL] [Abstract][Full Text] [Related]
50. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
[TBL] [Abstract][Full Text] [Related]
51. Tracking of enantioselective solubility of rac-norgestrel in the presence of cyclodextrin by a CD spectroscopic method.
Szegvári D; Zelkó R; Horváth P; Gergely A
Chirality; 2006 Feb; 18(2):121-6. PubMed ID: 16385617
[TBL] [Abstract][Full Text] [Related]
52. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
53. Inclusion complexation of p-hydroxybenzoic acid esters with 2-hydroxypropyl-beta-cyclodextrins. On changes in solubility and antimicrobial activity.
Matsuda H; Ito K; Sato Y; Yoshizawa D; Tanaka M; Taki A; Sumiyoshi H; Utsuki T; Hirayama F; Uekama K
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1448-52. PubMed ID: 8403092
[TBL] [Abstract][Full Text] [Related]
54. Improvement of the Ocular Bioavailability of Econazole Nitrate upon Complexation with Cyclodextrins.
Abd El-Gawad AEH; Soliman OA; El-Dahan MS; Al-Zuhairy SAS
AAPS PharmSciTech; 2017 Jul; 18(5):1795-1809. PubMed ID: 27830515
[TBL] [Abstract][Full Text] [Related]
55. Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis.
Cevher E; Açma A; Sinani G; Aksu B; Zloh M; Mülazımoğlu L
Int J Biol Macromol; 2014 Aug; 69():124-36. PubMed ID: 24857873
[TBL] [Abstract][Full Text] [Related]
56. Cyclodextrins as pharmaceutical solubilizers.
Brewster ME; Loftsson T
Adv Drug Deliv Rev; 2007 Jul; 59(7):645-66. PubMed ID: 17601630
[TBL] [Abstract][Full Text] [Related]
57. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
Arima H; Motoyama K; Higashi T
Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
[TBL] [Abstract][Full Text] [Related]
58. Cyclodextrin complexes: Perspective from drug delivery and formulation.
Jacob S; Nair AB
Drug Dev Res; 2018 Aug; 79(5):201-217. PubMed ID: 30188584
[TBL] [Abstract][Full Text] [Related]
59. Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins.
Nakanishi K; Nadai T; Masada M; Miyajima K
Chem Pharm Bull (Tokyo); 1992 May; 40(5):1252-6. PubMed ID: 1394642
[TBL] [Abstract][Full Text] [Related]
60. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
